- Johnson Johnson: Changing health for humanity
Johnson Johnson MedTech innovates at the intersection of biology and technology With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases
- Explore current job openings | Johnson Johnson | Johnson Johnson . . .
Explore exciting job openings at J J Search global roles in healthcare and join a team committed to innovation, growth and a healthier future for all
- Johnson Johnson、8月1日世界肺がんデーに肺がん患者さんとご家族のための「Value of Time」キャンペーンを開始 . . .
Johnson Johnson（日本における医療用医薬品事業の法人名：ヤンセンファーマ株式会社、本社：東京都千代田区、代表取締役社長：クリス・リーガー、以下「J J」）は、2025年8月1日の世界肺がんデーに、肺がんと診断された患者さんが、ご家族や大切な人と過ごすかけがえのない時間への希望を
- Explore careers at Johnson Johnson | Johnson Johnson Careers
Elevate your career with J J Discover global job opportunities to drive innovation, impact lives and grow in a supportive, mission-driven culture
- Johnson Johnson Reports Q2 2025 Results; Raises 2025 Outlook
NEW BRUNSWICK, N J --(BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for second-quarter 2025 “Today’s strong results reflect the depth and strength of Johnson Johnson’s uniquely diversified business operating across both MedTech and Innovative Medicine,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson Johnson
- Our history - Johnson Johnson
The brother of Johnson Johnson cofounders Robert Wood Johnson and James Wood Johnson, Edward Mead Johnson led the company’s sales and marketing division in the 19 th century In 1898, Edward Mead left Johnson Johnson, taking with him the company’s digestive products line, a business that would eventually become a leading global company in the field of infant and child nutrition
- Gen AI
Explore Gen AI, a platform created with create-react-app for innovative solutions and advancements in artificial intelligence
- Johnson Johnson Reports Q4 and Full-Year 2024 Results
NEW BRUNSWICK, N J --(BUSINESS WIRE)-- Johnson Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2024 "2024 was a transformative year for Johnson Johnson, marked by strong growth, an accelerating pipeline and industry-leading investments in innovation,” said Joaquin Duato, Chairman and Chief Executive Officer, Johnson Johnson
|